Metropolitan Life Insurance Company (MetLife)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$1.43M Sell
2023
Q4
$1.34M Sell
2023
Q3
$1.41M Sell
2023
Q2
$1.74M Sell
2023
Q1
$2.27M Sell
2022
Q4
$3.29M Sell
2022
Q3
$2.28M Sell
2022
Q2
$2.87M Sell
2022
Q1
$3.62M Sell
2021
Q4
$14M Sell
2021
Q3
$21.8M Buy
2021
Q2
$5.51M Buy
2021
Q1
$2.72M Sell
2020
Q4
$2.27M Sell
2020
Q3
$1.56M Buy
2020
Q2
$1.37M Buy
2020
Q1
$438K Buy
2019
Q4
$273K Sell
2019
Q3
$224K Buy
2019
Q2
$26.5K Sell
2019
Q1
$37.7K Buy